Health Condition 1: null- Newly diagnosed with vertigo of known or unknown origin
Conditions
Interventions
None listed
Sponsors
Abbott India Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male or female patients aged >=18 years. 2.Patients newly diagnosed with vertigo of known or unknown origin. 3.Patients who are willing to provide written patient authorization
Exclusion criteria
Exclusion criteria: The patients with following condition/disorder will be excluded from the Registry: 1. Patients already on treatment for vertigo. 2. Patients with new vertigo requiring hospitalization for any cause. 3. Female patients who are pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Clinical and demographic characteristics of patients with vertigo (in terms of age, gender and concomitant illness) 2. Percentage of patients with different causes of vertigo 3. Clinical presentation of different types of vertigoTimepoint: At end of study (around twelfth week) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Anti-vertigo treatment (name of drug, dosage, and administration route)Timepoint: At end of study (around twelfth week);Change in impact of vertigo on patientâ??s life from baseline to different follow-up visitsTimepoint: At end of each follow up visit from baseline;Percentage of patients with different anti-vertigo therapyTimepoint: At end of study (around twelfth week);Percentage of patients with different anti-vertigo therapy as per the causeTimepoint: At end of study (around twelfth week);Percentage of patients with recurrent vertigo at follow-up visits and its association with anti-vertigo treatment, if anyTimepoint: At end of study (around twelfth week) | — |
Countries
India
Contacts
Public ContactDr Kushal Sarda
Abbott India Limited
Outcome results
None listed